Article

Vitamin D Crucial Linked to More than 200 Genes

Vitamin D's interaction with our DNA was mapped by researchers at the University of Oxford, which demonstrated its influence over 200 genes.

Vitamin D’s interaction with our DNA was mapped by researchers at the University of Oxford, which demonstrated its influence over 200 genes.

Insufficient sun exposure and poor diet have been thought to contribute to the growing numbers of vitamin D deficiency sufferers and now the research proves the condition can increase susceptibility to autoimmune diseases, including rheumatoid arthritis, type 1 diabetes, and multiple sclerosis.

A recent study published in the journal Genome Research demonstrates just how vitamin D interacts with DNA. The team used DNA sequencing technology to create a map of vitamin D receptor binding across the genome. The receptor is activated by vitamin D, attaches itself to DNA, and then influences what proteins are made from our genetic code.

There were 2,776 binding sites found along the length of the genome, according to the press release. These sites were also concentrated near a number of genes associated with susceptibility to autoimmune conditions such as MS, Crohn’s disease, systemic lupus erthematosus, and rheumatoid arthritis as well as cancers such as chronic lymphocytic leukemia and colorectal cancer.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
© 2024 MJH Life Sciences

All rights reserved.